APL-045

N/A

Report date: 2025/08/06 16:50:00
NME

Base Information

Drug NameAPL-045
Drug Alias NameAPL-045
ClassificationSmall molecules
Mechanisms of ActionEukaryotic Translation Initiation Factor 2 Alpha Kinase 3 inhibitors
TargetsEukaryotic Translation Initiation Factor 2 Alpha Kinase 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApollo Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesApollo Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A